HK1135019A1 - Use of l-carnitine for the preparation of a medicament in the form of eye- drops for treating corneal diseases l- - Google Patents

Use of l-carnitine for the preparation of a medicament in the form of eye- drops for treating corneal diseases l-

Info

Publication number
HK1135019A1
HK1135019A1 HK09112163.7A HK09112163A HK1135019A1 HK 1135019 A1 HK1135019 A1 HK 1135019A1 HK 09112163 A HK09112163 A HK 09112163A HK 1135019 A1 HK1135019 A1 HK 1135019A1
Authority
HK
Hong Kong
Prior art keywords
carnitine
medicament
drops
eye
preparation
Prior art date
Application number
HK09112163.7A
Other languages
English (en)
Inventor
Aleardo Koverech
Nicola Pescosolido
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1135019A1 publication Critical patent/HK1135019A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK09112163.7A 2006-12-11 2009-12-24 Use of l-carnitine for the preparation of a medicament in the form of eye- drops for treating corneal diseases l- HK1135019A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125770 2006-12-11
PCT/EP2007/062610 WO2008071524A1 (fr) 2006-12-11 2007-11-21 Utilisation de la l-carnitine pour la préparation d'un médicament sous la forme de collyre pour le traitement de maladies de la cornée

Publications (1)

Publication Number Publication Date
HK1135019A1 true HK1135019A1 (en) 2010-05-28

Family

ID=37603705

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09112163.7A HK1135019A1 (en) 2006-12-11 2009-12-24 Use of l-carnitine for the preparation of a medicament in the form of eye- drops for treating corneal diseases l-

Country Status (13)

Country Link
US (1) US8158679B2 (fr)
EP (1) EP2091529A1 (fr)
JP (1) JP5384362B2 (fr)
KR (1) KR101447601B1 (fr)
CN (1) CN101534812B (fr)
AU (1) AU2007332680B2 (fr)
BR (1) BRPI0720089A2 (fr)
CA (1) CA2667069C (fr)
EA (1) EA017752B1 (fr)
HK (1) HK1135019A1 (fr)
MX (1) MX2009005503A (fr)
SG (1) SG176481A1 (fr)
WO (1) WO2008071524A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008077712A1 (fr) * 2006-12-22 2008-07-03 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel utile pour l'administration de médicaments ophtalmiques
TW201322982A (zh) * 2011-11-01 2013-06-16 Otsuka Pharma Co Ltd 用於治療前眼疾病之藥劑，該藥劑包含瑞巴派特及眼淚保持劑
EP2783695A1 (fr) * 2013-03-28 2014-10-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Supplément physioloqiue ou médicament à usage ophtalmique contenant de la L-carnitine ou des L-carnitines alcanoyles en combinaison avec eledoisin
FR3019465B1 (fr) 2014-04-02 2017-06-23 Horus Pharma Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08133968A (ja) * 1994-09-14 1996-05-28 Taisho Pharmaceut Co Ltd 角膜障害修復用点眼液
DE69919379T2 (de) * 1998-11-13 2005-09-08 Continental Projects Ltd. Komplexe von hyaluronic saure/carnitinen und pharmazeutische und kosmetische zusammensetzungen
RU2165749C1 (ru) * 2000-07-06 2001-04-27 Общество с ограниченной ответственностью "Научно-экспериментальное производство Микрохирургия глаза" Способ восстановления эндотелия роговицы
US7465463B2 (en) * 2002-09-04 2008-12-16 Polyheal, Ltd. Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
WO2006044155A2 (fr) 2004-10-01 2006-04-27 Lindstrom Richard L Compositions ophtalmiques comprenant un lubrifiant, un agent deturgescent, ainsi qu'un glycosaminoglycane et methodes d'utilisation de ces dernieres
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
KR101401353B1 (ko) * 2005-07-01 2014-05-29 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 점안약의 형태로 안구 사용을 위한 생리적 보조제 또는의약품의 제조를 위한 ｌ-카르니틴 또는 알카노일ｌ-카르니틴의 용도

Also Published As

Publication number Publication date
SG176481A1 (en) 2011-12-29
AU2007332680B2 (en) 2013-02-07
CA2667069C (fr) 2015-05-26
EA017752B1 (ru) 2013-02-28
CN101534812A (zh) 2009-09-16
KR20090087453A (ko) 2009-08-17
EP2091529A1 (fr) 2009-08-26
JP2010512363A (ja) 2010-04-22
AU2007332680A1 (en) 2008-06-19
KR101447601B1 (ko) 2014-10-07
US8158679B2 (en) 2012-04-17
EA200970562A1 (ru) 2009-10-30
JP5384362B2 (ja) 2014-01-08
MX2009005503A (es) 2009-06-04
US20100068300A1 (en) 2010-03-18
BRPI0720089A2 (pt) 2013-12-24
CN101534812B (zh) 2012-09-05
WO2008071524A1 (fr) 2008-06-19
CA2667069A1 (fr) 2008-06-19

Similar Documents

Publication Publication Date Title
IL217901B (en) Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases
HK1118721A1 (en) Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops l- l-
IL190284A (en) Use of milenzipran, or a suitable pharmaceutical salt, in the preparation of a drug for the treatment of fibromyalgia
IL221795B (en) Use of a pharmaceutical preparation of methylnaltrexone or a salt thereof for the preparation of a medicine for the treatment of side effects of treatment with opiates
HK1166263A1 (en) Use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
IL197442A (en) Therapeutic compositions containing glp-elp fusion proteins and their use in preparing a drug
HK1184701A1 (en) Use of glycosaminoglycan containing a binded hydrophobic group in the preparation of medicine for treating or preventing corneal epithelial layer disorders
IL197169A0 (en) Use of fgf-18 in the manufacture of a medicament for treatment of cartilage disorders
IL200278A (en) Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness
HK1150390A1 (en) A pharmaceutical composition and the application thereof in the preparation of medicine for the treatment of cerebrovascular diseases
EP2094281A4 (fr) Utilisation de conjugués lipidiques dans le traitement de maladies ou de troubles oculaires
IL200947A (en) Desprithiocine polyether analogues and their use in the preparation of drugs for the treatment of diseases
SI2148667T1 (sl) Uporaba derivatov cikloheksanheksola pri zdravljenju okularnih bolezni
IL194880A (en) Aminazole amine derivatives, their use in the treatment of diseases and pharmaceuticals containing them
IL240394B (en) Use of alemtuzumab to prepare a drug for use as a secondary treatment in multiple sclerosis
IL205290A (en) A variant of human neurorthin protein, or its active biological part, containing medicinal preparations, and its use in the preparation of therapeutic drugs
ZA201007391B (en) Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium in the blood
SI2379066T1 (sl) Uporaba opioidnih antagonistov za pripravo zdravila za zdravljenje degenerativnih bolezni retine
HK1135019A1 (en) Use of l-carnitine for the preparation of a medicament in the form of eye- drops for treating corneal diseases l-
PL2640364T3 (pl) Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych
IL218230B (en) Use of lapatinib or an acceptable pharmaceutical salt or preparation thereof for the preparation of a drug for the treatment of cancer
PT2603238E (pt) Métodos e composições farmacêuticas para o tratamento de uma doença ocular num indíviduo
EP2005964A4 (fr) Médicament pour traiter l'hyperphosphatémie et son procédé de préparation
IL216717A (en) Use of benzidamine in the manufacture of a drug for the treatment of p40-dependent diseases
PL1714647T3 (pl) Zastosowanie agomelatyny do wytwarzania leku do leczenia zaburzeń dwubiegunowych

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161121